Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis...
Via Business of Cannabis Mere hours after the results of the US election became clear, sending North American cannabis stocks into free fall, Germany’s ruling traffic...
It is the first comprehensive review of evidence on medical cannabis and epilepsy for clinicians, patients, and regulators.
The number of items prescribed in the UK’s private medical cannabis market has doubled each year since 2021.
The French ANSM assured at the beginning of the year that cannabis-based treatments would be available by 2025.
94% reported they consume cannabis for at least one medical or health reason.
A new report urges housing providers to support tenants who may be prescribed cannabis-based medicines.
The partnership aims to improve treatment options available to patients with chronic pain.
Experts are urging clinics to follow best practice guidelines as the industry reaches a 'tipping point'.
The UK’s Food Standards Agency (FSA) has issued its first positive safety assessment for a consortium application in its CBD Novel Foods approval process, seeing the...
